RecruitingNot Applicable

CARE Tool Study Aim 3

United States430 participantsStarted 2026-07-01

Plain-language summary

This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients with cancer overcome barriers they face navigating insurance and accessing financial resources.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for Implementation champions: \- Members of the cancer care team (e.g., physicians, nurses, research coordinators, financial navigators, social workers) that work with patients receiving treatment for gynecologic, lung, prostate, or colorectal cancer; or members of the billing team and employee of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital Exclusion Criteria for Implementation champions: * Implementation champions are ineligible if they are non-employees of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital * Do not treat patients for gynecologic, prostate, lung, or colorectal cancer Inclusion Criteria for Patients: * Age 18 and over * Primary or recurrent diagnosis of gynecologic, prostate, lung, or colorectal cancer in the last 12 months * Receiving cancer treatment from Siteman Cancer Center, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital * Self-reported ability to read and speak English Exclusion Criteria for Patients: * Under the age of 18 * Not diagnosed with gynecologic, prostate, lung, or colorectal cancer within the previous 12 months from recruitment * Not receiving care at Siteman Cancer Center, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital * Cannot give consent due to cognitive or emotional bar…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient's comprehensive score for financial toxicity (COST)

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)

Patient's score of self-efficacy for communicating about care costs measured with the Decision Self-Efficacy Scale

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)

Patient's health insurance literacy measure (HILM) score

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)

Trial details

NCT IDNCT07296887

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-07-31

Contact for this trial

Ashley Housten, OTD, MSCI, OTR/L

314-454-7958 ahousten@wustl.edu

View on ClinicalTrials.gov More Gynecologic Cancer trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Patient's comprehensive score for financial toxicity (COST)

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)

Patient's score of self-efficacy for communicating about care costs measured with the Decision Self-Efficacy Scale

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)

Patient's health insurance literacy measure (HILM) score

Timeframe: Completion of initial survey to completion of follow up survey (total estimated time is 3 months)